Welcome to LookChem.com Sign In|Join Free
  • or
3,4-METHYLENEDIOXYBENZYLIDINEBENZYLAMINE, also known as MDA, is a psychoactive chemical compound belonging to the phenethylamine class of drugs. It is closely related to MDMA, also known as ecstasy, and is recognized for its empathogenic and hallucinogenic effects. MDA functions as a serotonin-norepinephrine-dopamine releasing agent and reuptake inhibitor, which results in increased levels of these neurotransmitters in the brain.
Used in Recreational Settings:
MDA is used recreationally for its euphoric and psychedelic effects. It is sought after for its ability to induce feelings of empathy, emotional closeness, and heightened sensory perception.
Used in Research:
MDA is also used in scientific research to study the effects of psychoactive substances on the brain and their potential therapeutic applications.
Used in Controlled Environments:
Due to its psychoactive properties and potential risks, MDA is classified as a controlled substance in many countries. It is illegal to manufacture, distribute, or possess without proper authorization, and its use is restricted to controlled environments where it can be monitored and regulated.

112776-37-1

Post Buying Request

112776-37-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

112776-37-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 112776-37-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,7,7 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 112776-37:
(8*1)+(7*1)+(6*2)+(5*7)+(4*7)+(3*6)+(2*3)+(1*7)=121
121 % 10 = 1
So 112776-37-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10NO2P/c13-5-10-4-7-1-2-8-9(3-7)12-6-11-8/h1-3,5H,4,6,13H2/b10-5+

112776-37-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (44534)  N-Benzylidene-3,4-(methylenedioxy)benzylamine, 98+%   

  • 112776-37-1

  • 1g

  • 352.0CNY

  • Detail
  • Alfa Aesar

  • (44534)  N-Benzylidene-3,4-(methylenedioxy)benzylamine, 98+%   

  • 112776-37-1

  • 5g

  • 1411.0CNY

  • Detail
  • Alfa Aesar

  • (44534)  N-Benzylidene-3,4-(methylenedioxy)benzylamine, 98+%   

  • 112776-37-1

  • 25g

  • 5625.0CNY

  • Detail

112776-37-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(1,3-benzodioxol-5-ylmethyl)-1-phenylmethanimine

1.2 Other means of identification

Product number -
Other names benzylidene-piperonyl-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112776-37-1 SDS

112776-37-1Relevant academic research and scientific papers

Synthesis of chromeno[3,4-b]piperazines by an enol-ugi/reduction/cyclization sequence

Bornadiego, Ana,Neo, Ana G.,Marcos, Carlos F.

supporting information, (2021/05/31)

Keto piperazines and aminocoumarins are privileged building blocks for the construction of geometrically constrained peptides and therefore valuable structures in drug discovery. Combining these two heterocycles provides unique rigid polycyclic peptidomimetics with drug-like properties including many points of diversity that could be modulated to interact with different biological receptors. This work describes an efficient multicomponent approach to condensed chromenopiperazines based on the novel enol-Ugi reaction. Importantly, this strategy involves the first reported post-condensation transformation of an enol-Ugi adduct.

Synthesis, characterization, biological evaluation, and molecular docking studies of some piperonyl-based 4-thiazolidinone derivatives

Genc Bilgicli, Hayriye,Taslimi, Parham,Akyuz, Busra,Tuzun, Burak,Gulcin, ?lhami

, (2019/12/03)

Heterocyclic compounds are of particular importance among pharmacologically active compounds. In this study, some piperonyl-based 4-thiazolidinone derivatives (2a–i) were synthesized and characterized by spectroscopic assays. All molecules were tested as enzyme inhibitory factors. These compounds were effective inhibitors of the enzymes acetylcholinesterase (AChE), α-glycosidase (α-Gly), and the human carbonic anhydrase I and II isoforms (hCA I and II), with Ki values in the range of 8.90–66.51 nM for α-Gly, 94.8–289.5 nM for hCA I, 106.3–304.6 nM for hCA II, and 0.55–2.36 nM for AChE. The synthesized molecules were also studied theoretically. Molecular docking calculations were performed to investigate the interaction between the target protein and molecules. CA inhibitor compounds have been clinically used for almost 60 years as antiglaucoma and diuretic drugs. The inhibition of the AChE enzyme results in the blockage of ACh hydrolysis. On the contrary, the design of inhibitor compounds or/and modulators for AChE is of major interest as it is one of the most popular tools to prevent Alzheimer's disease.

Synthesis of polyheterocyclic pyrrolo[3,4-b]pyridin-5-ones via a one-pot (Ugi-3CR/aza diels-alder/N-acylation/aromatization/SN2) process. A suitable alternative towards novel Aza-analogues of falipamil

Zamudio-Medina, Angel,García-González, Ailyn N.,Herrera-Carrillo, Genesis K.,Zárate-Zárate, Daniel,Benavides-Macías, Adriana,Tamariz, Joaquín,Ibarra, Ilich A.,Islas-Jácome, Alejandro,González-Zamora, Eduardo

, (2018/04/06)

We describe the one-pot synthesis of twenty polyheterocyclic pyrrolo[3,4-b]pyridin-5-ones via a cascade process (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization) in 20 to 95% overall yields, as well as four pharmacologically promising analogues via an improved cascade process (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization/SN2): two piperazine-linked pyrrolo[3,4b]pyridin-5-ones in 33 and 34%, and a couple of Falipamil aza-analogues in 30 and 35% overall yields. It is worth highlighting the good substrate scope found, because final products are furnished with alkyl, aryl, and heterocyclic substituents. The use of chain-ring tautomerizable isocyanides (as key reagents for the Ugi-type three component reaction) allowed for a rapid and efficient assembly of the polysubstituted oxindoles, which were used in situ toward the complex products, conferring features like robustness, sustainability, and the one-pot approach to this synthetic methodology.

Highly efficient iron phthalocyanine catalyzed oxidative synthesis of imines from alcohols and amines

Bala, Manju,Verma, Praveen Kumar,Kumar, Neeraj,Sharma, Upendra,Singh, Bikram

supporting information, p. 732 - 737 (2013/08/23)

An efficient iron phthalocyanine catalyzed method was developed for direct oxidative coupling of alcohols with amines to afford corresponding imines. The present protocol is applicable to various substituted aromatic and aliphatic alcohols and amines. The reaction is believed to proceed via activation of alcohols by iron phthalocyanines through Lewis acid-base interaction to form aldehydes, which by nucleophilic attack of amines are converted into the corresponding imines.

Dynamic kinetic asymmetric synthesis of substituted pyrrolidines from racemic cyclopropanes and aldimines: Reaction development and mechanistic insights

Parsons, Andrew T.,Smith, Austin G.,Neel, Andrew J.,Johnson, Jeffrey S.

supporting information; experimental part, p. 9688 - 9692 (2010/09/06)

An enantioselective preparation of 2,5-cis-disubstituted pyrrolidines has been achieved via a dynamic kinetic asymmetric transformation (DyKAT) of racemic donor-acceptor cyclopropanes and (E)-aldimines. Mechanistic studies suggest that isomerization of the aldimine or resultant iminium to the Z geometry is not a pathway that furnishes the observed 2,5-cis-disubstituted products.

Phosphatase inhibitors. III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase

Beers, Scott A.,Schwender, Charles F.,Loughney, Deborah A.,Malloy, Elizabeth,Demarest, Keith,Jordan, Jerold

, p. 1693 - 1701 (2007/10/03)

Further investigation of the structural requirements of a series of benzylphosphonic acid inhibitors of human prostatic acid phosphatase has led to the highly potent series of α-aminobenzylphosphonic acids. The α-benzylaminobenzylphosphonic acid, with an IC50 = 4 nM, exhibited a 3500-fold improvement in potency over the carbon analogue, α-phenylethyl. The enhanced potency may be due to a combination of four favorable interactions including those with the phosphate binding region, the presence the hydrophobic moieties of the benzylamino and phenylphosphonic acid, and a rigid conformer produced by an internal salt bridge between the phosphonate and the α-amino group. Replacement of the phosphonic acid moiety with a phosphinic or carboxylic acid as well as deletion of the benzyl substitution on the α-amino group led to great reductions in potency.

Synthesis of monocyclic &β-lactams incorporating an essential oil constituent in the ring

Varma, Luxmi R,Narayanan, C S

, p. 676 - 680 (2007/10/02)

A series of new monocyclic β-lactams has been prepared using acyl chlorides derived from 1-menthol, thymol and eugenol and Schiff bases derived from aromatic aldehydes and amines, and their antibacterial activity determined.The compounds have been charact

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 112776-37-1